PMC · DOI:10.1007/s10689-025-00510-7·November 18, 2025
Correction: Barriers and facilitators for medical oncologists in the further implementation of mainstream genetic testing in breast cancer care in the Netherlands
Chiem L de Jong, Gina Schijven, Ellen G Engelhardt, Agnes Jager, Margreet G. E. M. Ausems
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Figures2
Click any figure to enlarge with its caption.
Figure 2
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsBRCA gene mutations in cancer · Cancer Genomics and Diagnostics · Global Cancer Incidence and Screening